Responses
Regular and Young Investigator Award Abstracts
Immunotherapy Toxicities
1238 Risk evaluation of immune checkpoint inhibitor diabetes through islet autoantibodies & HLA types in a large, real-world cohort
Compose a Response to This Article
Other responses
No responses have been published for this article.
